Literature DB >> 7986225

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.

H H Euler1, J O Schroeder, P Harten, R A Zeuner, H J Gutschmidt.   

Abstract

OBJECTIVE: To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus erythematosus (SLE).
METHODS: A protocol of plasmapheresis (3 x 60 ml/kg) and subsequent high-dose pulse cyclophosphamide (36 mg/kg) followed by 6 months of peroral immunosuppression was used to treat 14 patients with severe SLE.
RESULTS: Rapid improvement was achieved in all patients. Immunosuppressants, including corticosteroids, were withdrawn at month 6 in 12 patients. Eight patients continued without treatment for a mean observation period of 5.6 years (46-91 months).
CONCLUSION: The results demonstrate that treatment-free clinical remission can be achieved in some patients with severe SLE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986225     DOI: 10.1002/art.1780371212

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Treatment of severe proliferative lupus nephritis: the current state.

Authors:  C C Mok; R W S Wong; K N Lai
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

Authors:  M G Danieli; M Cappelli; G Malcangi; F Logullo; A Salvi; G Danieli
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

Review 4.  Remission and withdrawal of therapy in lupus nephritis.

Authors:  Gabriella Moroni; Francesca Raffiotta; Claudio Ponticelli
Journal:  J Nephrol       Date:  2016-05-04       Impact factor: 3.902

Review 5.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

Review 6.  [Therapeutic plasma exchange 1996].

Authors:  U Weber; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-10-15

Review 7.  Treatment options for juvenile-onset systemic lupus erythematosus.

Authors:  Luis Carreño; Francisco Javier López-Longo; Carlos Manuel González; Indalecio Monteagudo
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Retrospective study of plasma exchange in children with systemic lupus erythematosus.

Authors:  Elizabeth C Wright; Kjell Tullus; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2004-08-05       Impact factor: 3.714

9.  Unilateral hemispheric primary angiitis of the central nervous system.

Authors:  Michael G Ho; Wanxing Chai; Harry V Vinters; Gasser Hathout; Shri Mishra; Catherine Yim; Miguel Valdes-Sueiras; Robert Nishimura
Journal:  J Neurol       Date:  2011-03-18       Impact factor: 4.849

Review 10.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.